School of Engineering, University of Liverpool, Liverpool, L69 7ZX, UK.
Drug Discovery, Delivery and Patient Care (DDDPC), School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames, Surrey, KT1 2EE, UK.
Int J Pharm. 2020 Apr 30;580:119245. doi: 10.1016/j.ijpharm.2020.119245. Epub 2020 Mar 20.
Patient to patient variability is one of the issues when administering medications to individuals with different health conditions, pharmacokinetic, age, fitness, gender, and race. This requires introducing smart and personalised drug delivery systems with controlled release profile manufactured using novel approaches. Additive manufacturing (AM) provides opportunities such as full customisation, design freedom, and on-site manufacturing, and materials recycling. As a result, the academic and industrial demand for additive manufacturing for drug delivery has been continuously increasing and showing impressive results for a wide range of products. This paper provides an extensive overview of AM technologies and their applications for drug delivery. The review discusses AM technologies including their working principles, processed materials, as well as current progress in drug delivery to produce personalized dosages for every patient with controlled release profile. AM potentials, industrial scale, and challenges are investigated with regards to practice and industrial applications. The paper covers novel possibilities of AM technologies and their pharmaceuticals applications, which indicate a promising healthcare future.
当给具有不同健康状况、药代动力学、年龄、健康状况、性别和种族的个体用药时,患者之间的变异性是一个问题。这需要引入智能和个性化的药物输送系统,这些系统具有使用新方法制造的控制释放特性。增材制造(AM)提供了全定制、设计自由度和现场制造以及材料回收等机会。因此,学术界和工业界对用于药物输送的增材制造的需求不断增加,并为各种产品带来了令人印象深刻的结果。本文对 AM 技术及其在药物输送中的应用进行了广泛的概述。本综述讨论了 AM 技术,包括其工作原理、加工材料以及在药物输送方面的最新进展,以生产具有控制释放特性的个性化剂量。针对实践和工业应用,研究了 AM 的潜力、工业规模和挑战。本文涵盖了 AM 技术及其药物应用的新可能性,这预示着有一个有前途的医疗保健未来。